The history of the discovery of classic antithrombotic drugs: aspirin, heparin and oral anticoagulants. A serendipitous event, with perseverance
Vol. 22 No. 1 (2018), History of Hematology
Vol. 22 No. 1 (2018)

The history of the discovery of classic antithrombotic drugs: aspirin, heparin and oral anticoagulants. A serendipitous event, with perseverance

History of Hematology
Published 2019-04-17
B Grand
Hospital Juan A Fernández CABA.
ISSN 2250-8309 (versión en línea) - ISSN 0329-0379 (versión impresa)
pdf (Español (España))

Keywords

aspirin, heparin, classic antithrombotic drugs, discovery

How to Cite

Grand, B. (2019). The history of the discovery of classic antithrombotic drugs: aspirin, heparin and oral anticoagulants. A serendipitous event, with perseverance. Journal of Hematology, 22(1), 95–102. Retrieved from https://revistahematologia.com.ar/index.php/Revista/article/view/117
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

El manejo convencional de los procesos trombóticos y de los desórdenes cardiovasculares ha tenido por muchos años a la aspirina, heparina y anticoagulantes anti-vitamina K como drogas de elección. La historia del descubrimiento y desarrollo de los agentes antitrombóticos clásicos es rica por sus lecciones de historia de la ciencia. Cada uno ha tenido su propio escenario, con numerosas dificultades, intereses económicos y la participación de personalidades de diferentes países y disciplinas. Su descubrimiento ha aportado elementos valiosos para la comprensión de la biología vascular y la fisiología de la hemostasia y la trombosis.

pdf (Español (España))

References

1. Mueller RL and Scheidt S. History of drugs for thrombotic disease. Circulation. 1994;89.432-449.
2. Owren Ch A. A History of Blood Coagulation. Rochester, Minnesota. Mayo Foundation for Medical Education and Research. 2001.
3. Los Griegos. HD Kito. Editorial EUDEBA. Edición 19.2004.
4. Aristotle. Meteoroly. http.classics.mit.edu./Aristotle/meteoroly.htlm
5. Handin RI. The History of Antithrombotic Therapy: The Discovery of Heparin, the Vitamin K Antagonists, and the Utility of Aspirin. Hematol Oncol Clin North Am. 2016 Oct;30(5):987-93.
6. Gómez-Outes A, Suárez-Gea ML, Calvo-Rojas G, Lecumberri R, Rocha E, Pozo-Hernández C, Terleira-Fernández AI, Vargas-Castrillón E. Discovery of anticoagulant drugs: a historical perspective. Curr Drug Discov Technol. 2012 Jun 1;9(2):83-104.
7. Shapiro S. Treating Thrombosis in the 21th Century. N Engl J Med. 2003;1762-64.
8. Gibson PC. Salicylic acid for coronary thrombosis? Lancet. 1948; 1:965.
9. Gibson PC. Aspirin in the treatment of vascular diseases. Lancet.1949;2:1172-1174.
10. Craven LL. Acetylsalicylic acid, possible preventive of coronary thrombosis. Ann West Med Surg. 1950; 4:95.
11. Craven LL. Experiences with aspirin in the nonspecific prophylaxis of coronary thrombosis. Miss Valley Med J. 1953; 75:38-40.
12. Craven LL. Prevention of coronary and cerebral thrombosis. Miss Valley Med J. 1956; 78:213-215.
13. Quick AJ. Bleeding time after aspirin injection. Lancet.1968;1:50.
14. Weiss HJ, Aledort LM, Kochwa S. The effect of salicylates on the hemostatic properties of platelets on man. J Clin Invest. 1968; 47:2169-2180.
15. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs. Nature. 1971; 231:232-235.
16. Harrison MJG, Marshall J, Meadows JC. Effect of aspirin in amaurosis fugax. Lancet. 1971; 231:232-235.
17. The Coronary Drug Project Research Group. Aspirin in coronary heart disease. J Chronic Dis. 1976;29b:625-642.
18. Boston Collaborative Drug Surveillance Group. Regular aspirin intake and acute myocardial infarction. BMJ. 1974;1:440-443.
19. ISIS-2 Collaborative Group. Lancet. 1988;2:349- 360.
20. Hernando ER. Historia de la heparina. Angiología. 2014;66(5):277-278.
21. Mc Lean J. The discovery of heparin. Circulation. 1959; 19:75-78.
22. Mc Lean J. The thromboplastic action of cephalin. Am J Physiol. 1918,47:328-341.
23. Crafoord C. Preliminary report on post-operative treatment with heparin as a preventive of thrombosis. Acta Chir Scand. 1937; 79:407-426.
24. Wright IS. Experience with anticoagulants. Circulation. 1959;19:110-113.
25. Hirsh, Jack. Critical decisions in Thrombosis and Hemostasis. London, B.C.Decker, 1998.
26. Schofield FW. Hemorrhagic sweet clover disease in cattle. Can Vet Rec.1922; 3:74-75.
27. Schipper IA. Sweet Clover Poisoning. North Dakota State University, Acts May 1914.
28. Dam H. Antihemorrhagic vitamin of the chick: occurrence and chemical nature. Nature. 1935; 135:652-653.29.
29. Wright IS. Experience with dicumarol in the treatment of coronary thrombosis with myocardial infarction. Am Heart J. 1946; 36:801-815.
30. Fareed J, Hoppensteadt DA, Fareed D, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Semin Thromb Hemost. 2008 Feb;34(1):58-73.

All material published in the journal HEMATOLOGÍA (electronic and print version) is transferred to the Argentinean Society of Hematology. In accordance with the copyright Act (Act 11 723), a copyright transfer form will be sent to the authors of approved works, which has to be signed by all the authors before its publication. Authors should keep a copy of the original since the journal is not responsible for damages or losses of the material that was submitted. Authors should send an electronic version to the email: revista@sah.org.ar

Downloads

Download data is not yet available.